Align Technology names Kevin Conroy as next board chairman

Align Technology, Inc. (Nasdaq: ALGN) announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, after more than 20 years of service on the company's board of directors.

Kevin Conroy will succeed Larkin as Chairman on the same date. Conroy has served as an independent director of Align since December 2023 and has chaired the Compensation and Human Capital Committee since January 2026.

Larkin will remain on the board and serve as a member of the Nominating and Governance Committee through December 31, 2026, to support the transition.

Conroy previously served as Chairman and Chief Executive Officer of Exact Sciences Corp. until its acquisition by Abbott Laboratories in March 2026, where he led the commercialization of Cologuard and grew the company to $3.25 billion in annual revenue. He also previously served as President and CEO of Third Wave Technologies and held leadership roles at GE Healthcare. He currently serves on the board of Abbott Laboratories.

Joe Hogan, Align's president and chief executive officer, said in a statement that Conroy "brings extensive experience as a board leader" and has "demonstrated a strong track record of creating stockholder value, and deep expertise in healthcare, technology, and strategy."

Larkin has been a board member since 2004 and previously served as President and Chief Executive Officer of Nellcor Puritan Bennett, where he grew the company to nearly $1 billion in revenue.

You May Also Be Interested In

• NovaRed Mining adds Katie Zacharia to its advisory board
• Cal-Maine Foods adds two independent directors, expanding board to ten
• Qualcomm to acquire AI software firm Modular Inc.